In a study conducted in Turkey, 3 patients were diagnosed with tuberculosis in the 3-year follow-up of 192 patients who were receiving anti-TNF therapy for rheumatologic disease; active tuberculosis development rate in this study is 1.5% 16. Here, TNF is linked to tuberculosis.